北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (5): 760-767. doi: 10.3969/j.issn.1671-167X.2017.05.004
王芳, 张琰琴, 丁洁, 俞礼霞
WANG Fang, ZHANG Yan-qin, DING Jie, YU Li-xia
摘要: 目的 探讨多重竞争性荧光PCR在X连锁Alport综合征分子诊断中的应用。方法 选择20例在北京大学第一医院确诊且未进行基因诊断的X连锁Alport综合征患者为研究对象,同时选择2例经多重连接依赖性探针扩增技术检测到COL4A5基因大片段缺失突变的患者作为阳性对照和1例经肾活检组织电子显微镜检查证实非Alport综合征的男性作为正常对照。首先应用多重竞争性荧光PCR技术扩增COL4A5基因53个外显子和4个参照基因,对于检测到COL4A5基因缺失第1外显子者,进而应用相同技术扩增COL4A5基因外显子1~4、COL4A6基因外显子1~4、两基因共用启动子以及3个参照基因;对于检测到拷贝数缺失者,应用琼脂糖凝胶电泳鉴定扩增后的PCR产物或直接测序。结果 两例阳性对照应用多重竞争性荧光PCR技术检测到的COL4A5基因缺失突变与应用多重连接依赖性探针扩增技术检测到的COL4A5基因缺失突变一致。20例患者中6例(30%)明确了基因型,其中2例患者具有累及COL4A5和COL4A6两个基因5'端的大片段缺失,2例患者具有累及COL4A5基因30个外显子以上的大片段缺失,1例患者具有累及COL4A5基因至少1个外显子的大片段缺失,1例患者具有COL4A5基因缺失13个碱基的小的缺失突变,未检测到重复突变。结论 多重竞争性荧光PCR技术可用于检测X连锁 Alport 综合征大片段缺失突变,是对该病分子诊断检测方法的重要补充。
中图分类号:
[1] Jais JP, Knebelmann B, Giatras I, et al. X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males[J]. J Am Soc Nephrol, 2000, 11(4): 649-657. [2] Wang F, Zhao D, Ding J, et al. Skin biopsy is a practical approach for the clinical diagnosis and molecular genetic analysis of X-linked Alport’s syndrome[J]. J Mol Diagn, 2012, 14(6): 586-593. [3] Kashtan CE, Ding J, Gregory M, et al. Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport syndrome research collaborative[J]. Pediatr Nephrol, 2013, 28(1): 5-11. [4] Bekheirnia MR, Reed B, Gregory MC, et al. Genotype-phenotype correlation in X-linked Alport syndrome[J]. J Am Soc Nephrol, 2010, 21(5): 876-883. [5] Cheong HI, Park HW, Ha IS, et al. Mutational analysis of COL4A5 gene in Korean Alport syndrome[J]. Pediatr Nephrol, 2000, 14(2): 117-121. [6] Kawai S, Nomura S, Harano T. The COL4A5 gene in Japanese Alport syndrome patients: spectrum of mutations of all exons. The Japanese Alport Network[J]. Kidney Int, 1996, 49(3): 814-822. [7] Ceulemans S, van der Ven K, del-Favero J. Targeted screening and validation of copy number variations[J]. Methods Mol Biol, 2012, 838: 311-328. [8] 张琰琴,赵丹,俞礼霞, 等. 多重连接依赖性探针扩增技术在X连锁Alport综合征基因诊断中的应用[J].中华医学杂志, 2012, 92(40): 2825-2829. [9] Hertz JM, Juncker I, Marcussen N. MLPA and cDNA analysis improves COL4A5 mutation detection in X-linked Alport syndrome[J]. Clin Genet, 2008, 74(6): 522-530. [10] Nabais Sá MJ, Fieremans N, de Brouwer APM, et al. Deletion of the 5' exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome[J]. J Med Genet, 2013, 50(11): 745-753. [11] Nozu K, Minamikawa S, Yamada S, et al. Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis[J]. J Hum Genet, 2017, 62(7): 733-735. [12] Nabais Sá MJ, Sampaio S, Oliveira A, et al. Collagen type Ⅳ-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 families[J]. Clin Genet, 2015, 88(5): 462-467. [13] Weber S, Strasser K, Rath S, et al. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy[J]. Pediatr Nephrol, 2016, 31(6): 941-955. [14] Du R, Lu C, Jiang Z, et al. Efficient typing of copy number variations in a segmental duplication-mediated rearrangement hotspot using multiplex competitive amplification[J]. J Hum Genet, 2012, 57(8): 545-551. [15] Wang F, Ding J, Guo S, et al. Phenotypic and genotypic features of Alport syndrome in Chinese children[J]. Pediatr Nephrol, 2000, 17(12): 1013-1020. [16] Martin P, Heiskari N, Zhou J, et al. High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing[J]. J Am Soc Nephrol, 1998, 9(12): 2291-2301. [17] Savige J, Gregory M, Gross O, et al. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy[J]. J Am Soc Nephrol, 2013, 24(3): 364-375. [18] Dahan K, Heidet L, Zhou J, et al. Smooth muscle tumors associated with X-linked Alport syndrome: carrier detection in females[J]. Kidney Int, 1995, 48(6): 1900-1906. [19] Thielen BK, Barker DF, Nelson RD, et al. Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth[J]. Hum Mutat, 2003, 22(5): 419. |
[1] | 杜燕燕,王健,贺兰,季丽娜,徐樨巍. 儿童川崎病合并轻微脑炎/脑病伴可逆性胼胝体压部病变综合征1例并文献复习[J]. 北京大学学报(医学版), 2022, 54(4): 756-761. |
[2] | 王芳,张琰琴,丁洁,俞礼霞. 多重竞争性荧光PCR检测X连锁Alport综合征大片段缺失突变[J]. 北京大学学报(医学版), 0, (): 760-767. |
[3] | 韩烨, 杜偲倩, 肖慧捷, 周颖, 丁洁, 丁娟娟, 崔一民. 他克莫司缓释剂治疗儿童原发性肾病综合征的药代动力学特点[J]. 北京大学学报(医学版), 0, (): 807-813. |
[4] | 韩烨, 杜偲倩, 肖慧捷, 周颖, 丁洁, 丁娟娟, 崔一民. 他克莫司缓释剂治疗儿童原发性肾病综合征的药代动力学特点[J]. 北京大学学报(医学版), 2017, 49(5): 807-813. |
[5] | 季丽娜, 耿海云, 晁爽. 儿童特异性日间尿频104例临床分析[J]. 北京大学学报(医学版), 2017, 49(5): 927-929. |
[6] | 季丽娜, 耿海云, 晁爽. 儿童特异性日间尿频104例临床分析[J]. 北京大学学报(医学版), 0, (): 0-封三. |
|